CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

healthcarebusinessreview
US
EUROPE
APAC

About us

  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Magazine
×
#

Healthcare Business Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review

Subscribe

loading

Thank you for Subscribing to Healthcare Business Review Weekly Brief

  • Home
  • News

Recommended picks

Must-Have Features of An Effective Healthcare Compliance Plan

Useful Tips to Boost Your Mental Health

Uses Of Internet Of Things (Iot) In The Veterinary Industry

Crankfrog, A National Payer Advisory Firm, Has Joined The Chartis Group

Populus Media Introduces HCP Reach Offering Through Partnership With Telerayvertica;

How Pharmacy Management System Turned A Boon For The Medical Industry

What is the Future of Healthcare Supply chain?

Top Cybersecurity Challenges Faced In Healthcare Sector

Must-Have Features of An Effective Healthcare Compliance Plan

Useful Tips to Boost Your Mental Health

Uses Of Internet Of Things (Iot) In The Veterinary Industry

Crankfrog, A National Payer Advisory Firm, Has Joined The Chartis Group

Populus Media Introduces HCP Reach Offering Through Partnership With Telerayvertica;

How Pharmacy Management System Turned A Boon For The Medical Industry

What is the Future of Healthcare Supply chain?

Top Cybersecurity Challenges Faced In Healthcare Sector

Can AI Help the Pharma Supply Chain Development?

Healthcare Business Review | Wednesday, February 03, 2021
Tweet

FREMONT, CA: Artificial Intelligence (AI) has proved itself as a game-changing technology, for every industry, and not just pharmaceuticals. In the past few years, people have witnessed the potential of AI, which can benefit the healthcare industry. AI is reinterpreting how scientists developed new drugs and discovered cures, along with how they diagnosed, and how drug adherence was dealt with.


Nevertheless, AI in the pharma supply chain has mainly been ignored in spite of having enormous technological and commercial opportunities in the industry. The time has come to make more investments in AI solutions, primarily targeting the established challenges with the pharma supply chain.


Big pharma is aware of the technological arms race carried out in the worldwide healthcare industry. Recently, people have witnessed an acquisition spree with a few large pharmaceutical companies grabbing biotech start-ups, devoting in state-of-the-art AI solutions, and hiring domestic data scientists to perform together with scientists. Moreover, technology in the pharma supply chain that links the lab to the market is holding up. With the globalization of the pharma industry and the demand growing for new product types, supply chains should also turn smarter.


An ideal supply chain for today and tomorrow is considered as one of the most reactive ones, but proactive as well. 


It has the potential to anticipate, as well as accommodate the present and future trends, steering the forces and challenges. Multiple stress factors force the pharma industry to settle in a while developing new and quality medicines at a very affordable price. Numerous stress factors are increasing each year and adding up to the present, the real challenge, especially for the supply chain management.


When it comes to ecological pressures, regulators are forcing stricter environmental controls throughout the design, manufacture, and transportation of the pharma products to help limit the carbon emissions, as well as lessen plastic and water wastes. Multifaceted biologic drugs and gene therapies are growing increasingly famous, but also release enormous challenges for manufacturing and distribution networks, because of their sensitivity and mini life-cycle.


Besides, populations all around the world are growing old, along with the occurrence of associated chronic diseases such as cardiovascular disease, diabetes, cancer, and dementia. The criminal marketplace that sells falsified medicine is now worth more than $200 billion each year, making the safety of medicine quality a priority, including the progress of tamper-proof packaging technologies.


Weekly Brief

loading
> <
  • Healthcare Facilities Management 2022

    Top Vendors

    Current Issue
  • Healthcare Bpo 2022

    Top Vendors

    Current Issue
  • Veterinary Solution 2022

    Top Vendors

    Current Issue
  • Healthcare Executive Search 2022

    Top Vendors

    Current Issue

Read Also

Keys Takeaway Of Mental Health Awareness

Keys Takeaway Of Mental Health Awareness

Top Benefits Of Healthcare Compliance Programs

Top Benefits Of Healthcare Compliance Programs

How Dentists Can Leverage Web Marketing To Expand Their Business

How Dentists Can Leverage Web Marketing To Expand Their Business

Five Ways To Optimize Healthcare Supply Chain

Five Ways To Optimize Healthcare Supply Chain
Sedgwick Completes Acquisition Of Orchid Medical

Sedgwick Completes Acquisition Of Orchid Medical

Five Healthcare Marketing Trends to Watch out for in 2022

Five Healthcare Marketing Trends to Watch out for in 2022

Solv Demonstrates its Commitment to Healthcare Price Transparency with ClearPrice Launch

Solv Demonstrates its Commitment to Healthcare Price Transparency with ClearPrice Launch

Key Medication Management Challenges Facing Healthcare Administrators

Key Medication Management Challenges Facing Healthcare Administrators
Loading...

Copyright © 2022 Healthcare Business Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.healthcarebusinessreview.com/news/can-ai-help-the-pharma-supply-chain-development-nwid-110.html